Longitudinal PET/CT imaging with iodine (¹²⁴I) evuzamitide reveals organ response to plasma cell immunotherapy in a patient with AL amyloidosis

Amyloid. 2024 Jun;31(2):148-149. doi: 10.1080/13506129.2023.2286427. Epub 2023 Nov 22.

Authors

Ronald Lands¹, Emily B Martin¹, Dustin Powell², Alan Stuckey¹, Bryan Whittle³, Spencer Guthrie⁴, Renju Raj¹, Stephen J Kennel¹, Jonathan S Wall¹

Affiliations

¹ University of TN Graduate School of Medicine, Knoxville, TN, USA.
² Hendersonville Radiologic Consultants, Hendersonville, NC, USA.
³ University of Tennessee Medical Center, Knoxville, TN, USA.
⁴ Attralus, Inc, San Francisco, CA, USA.

PMID: 37990984
PMCID: PMC11109018 (available on 2025-06-01)
DOI: 10.1080/13506129.2023.2286427

No abstract available

Publication types

Case Reports

MeSH terms

Humans
Immunoglobulin Light-chain Amyloidosis* / diagnostic imaging
Immunoglobulin Light-chain Amyloidosis* / pathology
Immunoglobulin Light-chain Amyloidosis* / therapy
Immunotherapy / methods
Iodine Radioisotopes* / therapeutic use
Plasma Cells / immunology
Plasma Cells / pathology
Positron Emission Tomography Computed Tomography* / methods

Substances

Iodine Radioisotopes

Grants and funding